Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration

被引：0
|
作者：
Fei Liang
Sheng Zhang
Qin Wang
Wenfeng Li
机构：
[1] Fudan University,Medical Oncology, Shanghai Cancer Center
[2] Zhongshan Hospital,Department of Biostatistics
[3] Fudan University,Department of Medical oncology
[4] Shanghai University of Engineering Science,undefined
[5] the affiliated hospital of Qingdao University,undefined
来源：
BMC Cancer | / 20卷
关键词：
Randomized trials; Clinical benefits; Immune checkpoint inhibitors; Cancer; Food and drug administration agency;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2020
    Kayki-Mutlu, Gizem
    Michel, Martin C.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (05) : 839 - 852
  • [42] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021
    Gizem Kayki-Mutlu
    Zinnet Sevval Aksoyalp
    Leszek Wojnowski
    Martin C. Michel
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, 395 : 867 - 885
  • [43] Three US Food and Drug Administration-approved therapies for chronic GVHD
    Zeiser, Robert
    Lee, Stephanie J.
    [J]. BLOOD, 2022, 139 (11) : 1642 - 1645
  • [44] US Food and Drug Administration-Approved Laboratory Tests After Caronia
    Allen, Timothy Craig
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (11) : 1543 - 1544
  • [45] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023
    Kayki-Mutlu, Gizem
    Aksoyalp, Zinnet Sevval
    Wojnowski, Leszek
    Michel, Martin C.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (05) : 2949 - 2970
  • [46] A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2022
    Gizem Kayki-Mutlu
    Zinnet Sevval Aksoyalp
    Leszek Wojnowski
    Martin C. Michel
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 1619 - 1632
  • [47] A COMPARISON OF ANTIEPILEPTIC DRUGS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION AND HEALTH CANADA
    Alsharaimy, F.
    Chong, D.
    Seoane-Vazquez, E.
    Rodriguez-Monguio, R.
    Eguale, T.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A199 - A199
  • [48] Postmarketing Safety of Vaccines Approved by the US Food and Drug Administration A Cohort Study
    Tau, Noam
    Yahav, Dafna
    Shepshelovich, Daniel
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 173 (06) : 445 - +
  • [49] Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
    Bai, Xiaoyin
    Jiang, Shiyu
    Zhou, Yangzhong
    Zhen, Hongnan
    Ji, Junyi
    Li, Yi
    Ruan, Gechong
    Yang, Yang
    Shen, Kaini
    Wang, Luo
    Li, Guanqiao
    Yang, Hong
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [50] Immune checkpoint inhibitors and timing of administration
    Dizman, Nazli
    Velazquez, Ana, I
    Duma, Narjust
    [J]. LANCET ONCOLOGY, 2022, 23 (02): : E56 - E56
12345